Table 1 Baseline characteristics of patients enrolled in the study
Parameter | IPL + Activa (study group) (n = 30) | IPL only (control group) (n = 34) |
|---|---|---|
Age (years) | 56.2 ± 13.1 | 49.1 ± 12.4 |
Gender (M/F) | 8/22 | 9/25 |
Ethnicity | ||
European | 27 (90%) | 30 (88%) |
Other | 3 (10%) | 4 (12%) |
Ocular rosacea | 6 (20%) | 4 (12%) |
Ocular allergy | 3 (10%) | 3 (9%) |
Duration of MGD (years) | 4.4 ± 2.5 | 5.1 ± 3.1 |
History of MGX | 15 (50%) | 20 (59%) |
History of MGP | 6 (20%) | 6 (18%) |